Boundless possibilities with our expertise in cytokine mimesis
Transforming the discovery and development of therapeutics in oncology, autoimmune disorders, and infectious disease
Medikine is employing a versatile drug discovery platform that generates modular cytokine-mimetic “PEPTIKINES” that are smaller in molecular size than, and structurally unrelated to, natural cytokine proteins. These PEPTIKINESᵀᴹ are further engineered with distinctive features and optimized therapeutic attributes not found in naturally occurring cytokines.
How We Get There
We have already had success in identifying PEPTIKINES for multiple receptor targets and will continue to explore the platform’s utility across the hundreds of cytokine receptor targets relevant to human disease. Through the lens of our expertise, we’re identifying the right investigational medicines that will push the boundaries of what success looks like for people living with cancer, autoimmune disorders, and infectious diseases.
Get to Know Us
Meet the accomplished team of industry veterans with decades of experience in pioneering drug discovery technology and developing immuno-oncology therapeutics.